Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

eyePoC

Financiado

Cerrado

Clinical validation of a new diagnostic and monitoring PoC medical device based...

Clinical validation of a new diagnostic and monitoring PoC medical device based on quantification of biomarkers in tear fluids to improve the quality of eye health care Ocular diseases are not only relevant social, sanitary and economic issues, but also a growing market opportunity in an increasingly ageing population. Ophthalmology is a health care area where the availability of easy to use poin... ver más

31/03/2015

Horus Pharma

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

HORUS PHARMA SAS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2015-03-31

PHC-12-2014-1: Clinical research for the validatio...

I+D

Cerrada hace 10 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

Horus Pharma

50.00K€ | Lider

BIOFTALMIK

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

DryEye Validation of a Novel Diagnostic Biomarker for Dry Eye Syndr... 71K€ Cerrado

RETOXY Clinical validation of retinal oximetry as a biomarker 71K€ Cerrado

BIOCUDET Identify and detect key ocular biomarkers towards personal m... 89K€ Cerrado

PID2019-111139RB-I00 LIPIDOMICA DE LA LAGRIMA EN LA PATOLOGIA DE OJO SECO: POTENC... 145K€ Cerrado

TACT Towards an objective and quantitative Assessment of human Co... 173K€ Cerrado

PaDiCare Patient empowered Diabetes care in ambulatory settings 71K€ Cerrado

Duración del proyecto: 5 meses Fecha Inicio: 2014-10-24
Fecha Fin: 2015-03-31

Líder del proyecto

HORUS PHARMA SAS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Ocular diseases are not only relevant social, sanitary and economic issues, but also a growing market opportunity in an increasingly ageing population. Ophthalmology is a health care area where the availability of easy to use point of care (PoC) medical devices based on biomarkers is fundamental for improving patient vision care, reducing number and frequency of sick leave and disability due to visual problems and for getting a significant reduction of overcrowding of ophthalmology units at health systems. The use of medical devices able to detect and measure biomarkers in human samples in a fast and non-invasive method will allow the easy introduction of these systems at the doctor’s office, thus enabling diagnosis of diseases in an objective manner and accurately monitoring of treatments effectiveness to be introduced into the standard clinical protocols. The present project is aimed to the clinical validation and market introduction of a device previously developed for ocular surface diseases (OSDs), named Tear Monitor and focused on diagnosis and monitoring of the Dry Eye and inflammation by measuring biomarkers in tears. For this purpose, two European SMEs specialised on ophthalmology establish a collaborative partnership to joint their respective expertises in a complementary synergism to reach the objectives proposed. Horus Pharma, a French pharmaceutical company, specialised on production, distribution and sales of pharmaceutical and biotech products for eye therapy and diagnostic; and Bioftalmik, a Spanish company specialised on biomarker discovery and development of medical devices for ophthalmology applications. This project is crucial for the economic growth and international expansion of both companies and constitutes the base for strategic development in the immediate future.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores